Brief: Armata Pharmaceuticals Announces Q1 2022 Results
12/05/2022 21:18
May 12 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2022
RESULTS AND
PROVIDES CORPORATE UPDATE
* ARMATA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.30
Source text for Eikon: ID:nPn3qPjLJa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles